8-K: Acadia Healthcare CFO Transition and Guidance Reaffirmation

Acadia Healthcare announces the appointment of David Duckworth as Interim CFO, succeeding Todd Young, and reaffirms its 2026 financial guidance.

Summary

• Acadia Healthcare Company, Inc. announced a change in its Chief Financial Officer role.
• Todd Young will resign as CFO effective April 30, 2026.
• David M. Duckworth has been appointed as the Interim Chief Financial Officer, effective May 1, 2026.
• Mr. Duckworth previously served as CFO from July 2012 to July 2023.
• The company has reaffirmed its financial guidance for the first quarter and full year of 2026.
• First quarter 2026 guidance includes revenue of $820-$830 million, Adjusted EBITDA of $130-$137 million, and Adjusted EPS of $0.25-$0.30.
• Full-year 2026 guidance includes revenue of $3.37-$3.45 billion, Adjusted EBITDA of $575-$610 million, and Adjusted EPS of $1.30-$1.55.
• Capital expenditures for the full year 2026 are projected to be between $255 to $280 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing due to the reaffirmation of financial guidance, which provides stability. However, the departure of a CFO and the appointment of an interim successor introduce a degree of uncertainty regarding long-term leadership.

Positives

• Reaffirmation of financial guidance for Q1 and full-year 2026 indicates confidence in continued performance.
• Appointment of David Duckworth as Interim CFO brings back experienced leadership with deep knowledge of the company.
• Mr. Duckworth's prior experience as CFO from 2012-2023 provides continuity and stability during the transition.
• The company is reaffirming its revenue, Adjusted EBITDA, and Adjusted EPS guidance for both the first quarter and the full year 2026.

Negatives

• Departure of the current CFO, Todd Young, to pursue a role at a private equity-backed company.
• The interim CFO appointment suggests the search for a permanent CFO is ongoing, indicating potential uncertainty in long-term leadership.
• The company's financial guidance is subject to various risks and uncertainties outlined in the forward-looking statements.

Risks

• Potential difficulties in integrating acquired facilities or realizing expected benefits and synergies.
• Challenges in adding beds, expanding services, enhancing marketing, and improving efficiencies.
• Potential reductions in payments from government and commercial payors, particularly due to changes in Medicaid financing mechanisms like the One Big Beautiful Bill Act (OBBBA).
• Risk of patient incidents, governmental investigations, litigation, and adverse regulatory actions.
• The possibility of not generating sufficient cash from operations to service debt and meet working capital and capital expenditure requirements.
• Changes in expectations resulting from actuarial and other reviews of liability reserves.
• Potential disruptions to information technology systems or cybersecurity incidents.
• General economic or industry conditions, including reduced admissions, increased costs, and changes in competition.

Future Outlook

The company is reaffirming its previously issued financial guidance for the first quarter and full year 2026, indicating confidence in its strategic execution and market position. The guidance includes specific ranges for revenue, Adjusted EBITDA, and Adjusted earnings per diluted share, as well as projected capital expenditures for the full year.

Management Comments

• "We are pleased to welcome David back as Interim Chief Financial Officer. He brings a deep understanding of Acadia, our operations, and our industry, along with strong relationships with the Companys leadership team and Board. Davids experience will be invaluable as we continue executing our strategic priorities to position Acadia for near and long-term success and value creation."
• "On behalf of the Board and our entire team, I want to thank Todd for his leadership and contributions during his time with Acadia. We appreciate his dedication and wish him all the best in his next chapter."

Industry Context

StockSavvy.ai notes that this CFO transition at Acadia Healthcare, a major player in the behavioral healthcare sector, occurs while the company reaffirms its financial guidance. This suggests operational stability despite leadership changes, a critical factor in the healthcare services industry which is sensitive to regulatory shifts and patient volume fluctuations.

Management Changes

Stakeholder Impact

• Shareholders: The reaffirmation of financial guidance provides a degree of certainty, while the CFO transition may introduce short-term uncertainty. The company's performance and strategic execution will be key.
• Employees: The transition may create some uncertainty, but the appointment of an experienced interim CFO aims to ensure operational continuity.
• Creditors: The reaffirmation of financial guidance and projected capital expenditures suggests continued focus on financial stability and operational needs.

Next Steps

• Acadia will issue its first quarter 2026 results after market close on April 29, 2026.
• The company will host its first quarter earnings call on April 30, 2026, at 9 a.m. Eastern Daylight Time.
• The search for a permanent Chief Executive Officer remains ongoing.
• David Duckworth is expected to serve as Interim Chief Financial Officer at least until the completion of the search for a permanent CEO.

Key Dates

Recommendation

The filing reaffirms financial guidance, which is positive, but the departure of the CFO and the appointment of an interim successor introduce a degree of uncertainty. While the interim CFO is experienced, the ongoing search for permanent leadership and the inherent risks in the behavioral healthcare sector warrant a cautious 'hold' stance until more clarity on long-term leadership and continued performance is established.

Keywords

Acadia Healthcare, CFO Transition, Interim CFO, David Duckworth, Todd Young, Financial Guidance, Behavioral Healthcare, 8-K Filing